Nasdaq:US$15.14 (-0.26) | HKEX:HK$23.76 (-0.70) | AIM:£2.20 (-0.14)
Search Result
Previous Article   |   Next Article
Announcements & Press Releases, Oncology / Immunology | 6 Jun 2012

Hutchison MediPharma Limited Announces Presentations of Sulfatinib and Fruquintinib Clinical Data at the 2012 ASCO Annual Meeting